Walleye Capital’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.7M | Buy |
21,488
+3,504
| +19% | +$767K | 0.02% | 410 |
|
2025
Q1 | $4.03M | Sell |
17,984
-30,675
| -63% | -$6.87M | 0.02% | 410 |
|
2024
Q4 | $15.9M | Buy |
48,659
+26,164
| +116% | +$8.57M | 0.04% | 167 |
|
2024
Q3 | $6.75M | Buy |
22,495
+20,959
| +1,365% | +$6.29M | 0.01% | 355 |
|
2024
Q2 | $506K | Buy |
1,536
+304
| +25% | +$100K | ﹤0.01% | 1450 |
|
2024
Q1 | $488K | Buy |
+1,232
| New | +$488K | ﹤0.01% | 1401 |
|
2023
Q4 | – | Sell |
-847
| Closed | -$318K | – | 3074 |
|
2023
Q3 | $318K | Buy |
+847
| New | +$318K | ﹤0.01% | 1315 |
|
2023
Q1 | – | Sell |
-4,509
| Closed | -$1.06M | – | 2789 |
|
2022
Q4 | $1.06M | Sell |
4,509
-5,267
| -54% | -$1.24M | 0.02% | 698 |
|
2022
Q3 | $2.41M | Buy |
9,776
+6,966
| +248% | +$1.71M | 0.05% | 384 |
|
2022
Q2 | $850K | Buy |
+2,810
| New | +$850K | 0.02% | 713 |
|